MedPath

COVID-19 Self-testing Study

Not Applicable
Completed
Conditions
COVID-19
Interventions
Behavioral: SMARTest mobile app for COVID-19 self-testing
Registration Number
NCT05701878
Lead Sponsor
Columbia University
Brief Summary

The goal of this clinical trial is to understand how the introduction of an app-based intervention changes knowledge, attitudes, and practices on COVID-19 self-testing.

Detailed Description

Rapid diagnostic testing has been shown to be an important tool in controlling the spread of the COVID-19 pandemic by identifying people when they are likely to be most contagious and reducing crowding at testing sites. In addition to employer-mandated testing, rapid antigen tests are becoming increasingly used by individuals. A method to promote frequent self-testing would help break the chain of viral transmission, slow the spread of disease, slow the spread of vaccine-resistant variants, and improve pandemic management.

The ubiquity of smartphones along with their data connectivity capabilities and onboard sensors make them an attractive tool to complement rapid diagnostic tests and an important component of decentralized testing. Smartphone-based tools have shown high acceptability among healthcare workers for the real-time tracking of rapid test results.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria
  • English-speaking
  • 18 years old or older
  • Owns a smartphone running either Android or iOS operating systems
  • Willing to download a COVID-19 self-testing app
  • Willing to receive and send text messages for the study (and fill out surveys linked from text messages)
Exclusion Criteria
  • Not willing to self-test themselves with COVID-19 rapid tests

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Intervention (App) GroupSMARTest mobile app for COVID-19 self-testingParticipants in this group will be given access to a COVID-19 self-testing app (SMARTest). Access to the app, given exclusively to this group, will be in addition to the 12 COVID-19 self-test kits participants receive.
Primary Outcome Measures
NameTimeMethod
COVID-19 Self-Testing Knowledge, Attitudes, and Practices Questionnaire Score - study initiationBaseline

COVID-19 Rapid Tests Knowledge, Attitudes, and Practices Questionnaire is a self-assessment measuring participant attitudes, knowledge, and practices toward COVID-19 rapid tests and self-testing.

COVID-19 Self-Testing Knowledge, Attitudes, and Practices Questionnaire Score - study completionAt study completion (About 1 month after enrollment)

COVID-19 Rapid Tests Knowledge, Attitudes, and Practices Questionnaire is a self-assessment measuring participant attitudes, knowledge, and practices toward COVID-19 rapid tests and self-testing.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

ICAP Harlem Prevention Center

🇺🇸

New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath